Medical Discovery News
Science permeates everyday life. Yet the understanding of advances in biomedical science is limited at best. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today for the medicine of tomorrow. Our weekly five-hundred-word newspaper column (http://www.illuminascicom.com/) and two-minute radio show provide insights into a broad range of biomedical science topics. Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine. Each release is designed to stimulate listeners to think, question and appreciate how science affects their health as well as that of the rest of the world. We also delve into significant biomedical discoveries and portray how science (or the lack of it) has impacted health throughout history.
Medical Discovery News
Where did the HIV Resistance Gene come From
Welcome to Medical Discovery News. I’m Dr. David Niesel.
And I’m Dr Norbert Herzog.
A gene mutation that can cure AIDS is now linked to people who lived near the Black Sea between the Stone Age and Viking Age. That’s up to nine thousand years ago.
The gene, CCR-five delta thirty-two, codes for a protein on immune cells and is how HIV enters some of those cells.
Bone marrow transplants with a mutated version of this gene have cured a handful of AIDS patients, and since then, the hunt has been on to trace the origin of this mutation.
About ten to sixteen percent of European genomes carry this variant. Researchers found it when they studied thousands of modern human genomes sourced from a project trying to catalog human gene variation.
They then searched for the variant among ancient genomes from about eight thousand BC to one thousand AD and hit the jackpot when it was traced to one of Europe’s early farmers near the Black Sea.
The mutation exploded between eight thousand and two thousand years ago, suggesting it was somehow advantageous to people then, long before HIV appeared in humans about a hundred years ago. The question being addressed by scientists is why.
One theory for why CCR-five delta 32endured is that it may have dampened the immune response as infectious disease became more common in a newly agrarian society. They would have had an advantage over people with an overly aggressive immune response that caused damage or death.
We’ll likely never know why the variant spread in people so long agoor why it is still present today, but recognize its value in fighting AIDS.
We are Drs. David Niesel and Norbert Herzog, at UTMB and Quinnipiac University, where biomedical discoveries shape the future of medicine. For much more and our disclaimer go to medicaldiscoverynews.com or listen to our podcast on your favorite podcast service.
